CA - Knight Therapeutics GAAP EPS of C$0.02 revenue of C$75.82M August, 11 2022 09:50 AM CA Inc. Knight Therapeutics press release ( OTCPK:KHTRF ): Q2 GAAP EPS of C$0.02. Revenue of C$75.82M (+15.2% Y/Y). For further details see: Knight Therapeutics GAAP EPS of C$0.02, revenue of C$75.82M